EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of antiseizure medication concentration ranges in blood samples using an automated big data approach

Mariam Nersesjan iD, Elke Hoffmann-Lücke, Eva Greibe, Per Hersom Aaslo, Lasse Kristoffer Bak, Lars Engers Pedersen, Palle Bach Nielsen Fruekilde, Anette Stark, Jakob Christensen iD, Andreas Brønden, Jens Borggaard Larsen iD

Epilepsia · 2025

DOI: 10.1111/epi.18330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Mariam Nersesjan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Monitoring, Epilepsy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of the study is to provide insight into the real‐world use of therapeutic drug monitoring ( TDM ) for the most common antiseizure medications ( ASMs ).

Methods

In total, 137 586 samples from the period 2019–2023 were collected from the five main Danish laboratories performing TDM. A previously described algorithm developed to exclude abnormal TDM results from patient data was applied. This resulted in the inclusion of 84 951 samples from 53 406 patients. Concentration ranges were calculated as 10th to 90th percentiles for the datasets of the ASMs: brivaracetam, carbamazepine, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital, topiramate, valproic acid, and zonisamide. The observed concentration ranges were compared to the established reference ranges from Danish laboratories, the International League Against Epilepsy (ILAE), and the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP). Furthermore, data were stratified based on sex, age groups (0–17, 18–64, and 65–100 years) and indication (all indications vs psychiatric indication).

Results

The observed concentration ranges showed good overall concordance with reference ranges from Danish laboratories except for levetiracetam, whereas the ranges for brivaracetam, lacosamide, lamotrigine, levetiracetam, valproic acid, and zonisamide were different from the AGNP and ILAE guidelines. Age‐related differences were identified for several of the drugs. The calculated range of lamotrigine was lower in samples requested from psychiatric departments compared to samples from non‐psychiatric departments. Significance The applied automated approach can facilitate a fast and efficient method for comparing established reference ranges with nationwide TDM datasets, thereby allowing continual monitoring of laboratory reference ranges. The findings from this study suggest that the Danish reference range for levetiracetam should be reevaluated. Furthermore, dose adjustment may be relevant for levetiracetam, topiramate, and lacosamide to account for age‐related changes in metabolism. The lower concentration range for lamotrigine in the psychiatric population indicates that it may be effective at lower concentrations in patients with bipolar disorder compared to patients with epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsDrug MonitoringEpilepsyHumansMaleFemaleMiddle AgedAdultAgedYoung AdultAdolescentChildAged, 80 and overChild, PreschoolInfantLevetiracetamLamotrigineLacosamideDenmarkInfant, NewbornCarbamazepineValproic AcidTopiramate

Stichwörter der Autor:innen

antiseizure medicationepilepsyretrospective cohorttherapeutic drug monitoringtherapeutic reference range

Substanzen

AnticonvulsantsLevetiracetamLamotrigineLacosamideCarbamazepineValproic AcidTopiramateZonisamideOxcarbazepinePhenobarbital

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
  • Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • The Laboratory of the Danish Epilepsy Centre-Filadelfia, Dianalund, Denmark.
  • Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
  • Translational Research Center (TRACE), Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.

ORCID-Profile: Mariam Nersesjan, Jakob Christensen, Jens Borggaard Larsen

Zitieren

APA

Nersesjan, M., Hoffmann-Lücke, E., Greibe, E., Aaslo, P. H., Bak, L. K., Pedersen, L. E., Fruekilde, P. B. N., Stark, A., Christensen, J., Brønden, A., & Larsen, J. B. (2025). Evaluation of antiseizure medication concentration ranges in blood samples using an automated big data approach. Epilepsia. https://doi.org/10.1111/epi.18330

Vancouver

Nersesjan M, Hoffmann-Lücke E, Greibe E, Aaslo PH, Bak LK, Pedersen LE, et al. Evaluation of antiseizure medication concentration ranges in blood samples using an automated big data approach. Epilepsia. 2025. doi:10.1111/epi.18330

BibTeX
@article{Nersesjan2025,
  author = {Nersesjan, Mariam and Hoffmann-Lücke, Elke and Greibe, Eva and Aaslo, Per Hersom and Bak, Lasse Kristoffer and Pedersen, Lars Engers and Fruekilde, Palle Bach Nielsen and Stark, Anette and Christensen, Jakob and Brønden, Andreas and Larsen, Jens Borggaard},
  title = {Evaluation of antiseizure medication concentration ranges in blood samples using an automated big data approach},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18330}
}
Kostenlos starten →